A nine-gene signature to improve prognosis prediction of colon carcinoma

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7–30.
   PubMed Web of Science ®Google Scholar
• Li C, Zheng H, Jia H, et al. Prognosis of three histological subtypes of colorectal adenocarcinoma: a retrospective analysis of 8005 Chinese patients. Cancer Med. 2019;8:3411–3419.
   PubMed Web of Science ®Google Scholar
• Zheng C, Jiang F, Lin H, et al. Clinical characteristics and prognosis of different primary tumor location in colorectal cancer: a population-based cohort study. Clin Transl Oncol. 2019;21:1524–1531.
   PubMed Web of Science ®Google Scholar
• Park YL, Kim S-H, Park S-Y, et al. Forkheadbox A1 regulates tumor cell growth and predicts prognosis in colorectal cancer. Int J Oncol. 2019;54:2169–2178.
   PubMed Web of Science ®Google Scholar
• Zhou R, Zhang J, Zeng D, et al. Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I-III colon cancer. Cancer Immunol Immunother. 2019;68:433–442.
   PubMed Web of Science ®Google Scholar
• Feng Z, Shi X, Zhang Q, et al. Analysis of clinicopathological features and prognosis of 1315 cases in colorectal cancer located at different anatomical subsites. Pathol Res Pract. 2019;215:152560.
   PubMed Web of Science ®Google Scholar
• Gong W, Li T. [Bioinformatical analysis of correlation between sulfatase-1 (SULF1) and prognosis of colon cancer and underlying mechanisms]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2019;35:1008–1013.
   PubMedGoogle Scholar
• Xu G, Zhang M, Zhu H, et al. A 15-gene signature for prediction of colon cancer recurrence and prognosis based on SVM. Gene. 2017;604:33–40.
   PubMed Web of Science ®Google Scholar
• Barbagallo C, Brex D, Caponnetto A, et al. LncRNA UCA1, upregulated in CRC biopsies and downregulated in serum exosomes, controls mRNA expression by RNA-RNA interactions. Mol Ther Nucleic Acids. 2018;12:229–241.
   PubMedGoogle Scholar
• Yan Y, Wang Z, Qin B. A novel long noncoding RNA, LINC00483 promotes proliferation and metastasis via modulating of FMNL2 in CRC. Biochem Biophys Res Commun. 2019;509:441–447.
   PubMed Web of Science ®Google Scholar
• Nguyen MN, Choi TG, Nguyen DT, et al. CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer. Oncotarget. 2015;6:31674–31692.
   PubMedGoogle Scholar
• Hua RX, Zhuo Z-J, Zhu J, et al. XPG gene polymorphisms contribute to colorectal cancer susceptibility: a two-stage case-control study. J Cancer. 2016;7:1731–1739.
   PubMed Web of Science ®Google Scholar
• Shahid M, Choi TG, Nguyen MN, et al. An 8-gene signature for prediction of prognosis and chemoresponse in non-small cell lung cancer. Oncotarget. 2016;7:86561–86572.
   PubMedGoogle Scholar
• Chen L, Zhu Z, Gao W, et al. Systemic analysis of different colorectal cancer cell lines and TCGA datasets identified IGF-1R/EGFR-PPAR-CASPASE axis as important indicator for radiotherapy sensitivity. Gene. 2017;627:484–490.
   PubMed Web of Science ®Google Scholar
• Vasquez MM, Hu C, Roe DJ, et al. Least absolute shrinkage and selection operator type methods for the identification of serum biomarkers of overweight and obesity: simulation and application. BMC Med Res Methodol. 2016;16(154). DOI:10.1186/s12874-016-0254-8
   PubMedGoogle Scholar
• Liang L, Zeng J-H, Qin X-G, et al. Distinguishable prognostic signatures of left- and right-sided colon cancer: a study based on sequencing data. Cell Physiol Biochem. 2018;48:475–490.
   PubMedGoogle Scholar
• Zhou R, Zeng D, Zhang J, et al. A robust panel based on tumour microenvironment genes for prognostic prediction and tailoring therapies in stage I-III colon cancer. EBioMedicine. 2019;42:420–430.
   PubMed Web of Science ®Google Scholar
• Gao P, He M, Zhang C, et al. Integrated analysis of gene expression signatures associated with colon cancer from three datasets. Gene. 2018;654:95–102.
   PubMed Web of Science ®Google Scholar
• Ning Y, Liu W, Guan X, et al. CPSF3 is a promising prognostic biomarker and predicts recurrence of non-small cell lung cancer. Oncol Lett. 2019;18:2835–2844.
   PubMed Web of Science ®Google Scholar
• Oshi M, Newman S, Murthy V, et al. ITPKC as a prognostic and predictive biomarker of neoadjuvant chemotherapy for triple negative breast cancer. Cancers (Basel). 2020;12(10). DOI:10.3390/cancers12102758.
   Web of Science ®Google Scholar
• Grone J, Lenze D, Jurinovic V, et al. Molecular profiles and clinical outcome of stage UICC II colon cancer patients. Int J Colorectal Dis. 2011;26:847–858.
   PubMed Web of Science ®Google Scholar
• Zhao ZR, Zhang L-J, He X-Q, et al. Significance of mRNA and protein expression of MAC30 in progression of colorectal cancer. Chemotherapy. 2011;57:394–401.
   PubMed Web of Science ®Google Scholar
• Kazama S, Kishikawa J, Tanaka T, et al. Immunohistochemical expression of CD133 and LGR5 in ulcerative colitis-associated colorectal cancer and dysplasia. In Vivo. 2019;33:1279–1284. DOI:10.21873/invivo.11600
   PubMed Web of Science ®Google Scholar
• Wang W, Wan L, Wu S, et al. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis. Cell Oncol (Dordr). 2018;41:495–504.
   PubMed Web of Science ®Google Scholar
• Feng B, Xu W-B, Zheng M-H, et al. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer. J Gastroenterol Hepatol. 2006;21:1596–1603.
   PubMed Web of Science ®Google Scholar
• Talieri M, Li L, Zheng Y, et al. The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer. Br J Cancer. 2009;100:1659–1665.
   PubMed Web of Science ®Google Scholar
• Alexopoulou DK, Papadopoulos IN, Scorilas A. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer. Clin Biochem. 2013;46:1453–1461.
   PubMed Web of Science ®Google Scholar
• Wang T, Lin F, Sun X, et al. HOXB8 enhances the proliferation and metastasis of colorectal cancer cells by promoting EMT via STAT3 activation. Cancer Cell Int. 2019;19:3.
   PubMed Web of Science ®Google Scholar
• Qi XW, Xia S-H, Yin Y, et al. Expression features of CXCR5 and its ligand, CXCL13 associated with poor prognosis of advanced colorectal cancer. Eur Rev Med Pharmacol Sci. 2014;18:1916–1924.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Zhang X, Guo H, et al. CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway. Mol Cell Biochem. 2015;400:287–295.
   PubMed Web of Science ®Google Scholar
• Toiyama Y, Fujikawa H, Kawamura M, et al. Evaluation of CXCL10 as a novel serum marker for predicting liver metastasis and prognosis in colorectal cancer. Int J Oncol. 2012;40:560–566.
   PubMed Web of Science ®Google Scholar
• Fang Y, Shen Z-Y, Zhan Y-Z, et al. CD36 inhibits beta-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis. Nat Commun. 2019;10:3981.
   PubMed Web of Science ®Google Scholar
• Sherafatian M, Arjmand F. Decision tree-based classifiers for lung cancer diagnosis and subtyping using TCGA miRNA expression data. Oncol Lett. 2019;18:2125–2131.
   PubMed Web of Science ®Google Scholar
• Najafi M, Farhood B, Mortezaee K. Extracellular matrix (ECM) stiffness and degradation as cancer drivers. J Cell Biochem. 2019;120:2782–2790.
   PubMed Web of Science ®Google Scholar
• Bao Y, Wang L, Shi L, et al. Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer. Cell Mol Biol Lett. 2019;24:38.
   PubMed Web of Science ®Google Scholar
• Tubbs A, Endogenous NA. DNA damage as a source of genomic instability in cancer. Cell. 2017;168:644–656.
   PubMed Web of Science ®Google Scholar